AR059126A1 - Uso de sales de tiotropio en el tratamiento del asma persistente moderada - Google Patents

Uso de sales de tiotropio en el tratamiento del asma persistente moderada

Info

Publication number
AR059126A1
AR059126A1 ARP070100019A ARP070100019A AR059126A1 AR 059126 A1 AR059126 A1 AR 059126A1 AR P070100019 A ARP070100019 A AR P070100019A AR P070100019 A ARP070100019 A AR P070100019A AR 059126 A1 AR059126 A1 AR 059126A1
Authority
AR
Argentina
Prior art keywords
treatment
salts
tiotrope
moderate asthma
persistent moderate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
ARP070100019A
Other languages
English (en)
Inventor
Michael Engel
Stefan Heinrichs
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Vetmedica GmbH
Boehringer Ingelheim Vetmedica de C V SA
Original Assignee
Boehringer Ingelheim Vetmedica GmbH
Boehringer Ingelheim Vetmedica de C V SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35695896&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR059126(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Vetmedica GmbH, Boehringer Ingelheim Vetmedica de C V SA filed Critical Boehringer Ingelheim Vetmedica GmbH
Publication of AR059126A1 publication Critical patent/AR059126A1/es
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Uso de sales de tiotropio para la preparacion de un medicamento destinado al tratamiento de pacientes que padecen asma persistente moderada. Reivindicacion 1: Uso de sales de tiotropio (1) en la que X- indica un anion con una sola carga negativa, preferiblemente un anion que se selecciona entre cloruro, bromuro, yoduro, sulfato, fosfato, metansulfonato, nitrato, maleato, acetato, citrato, fumarato, tartrato, oxalato, succinato, benzoato y p-toluensulfonato, opcionalmente en forma de los hidratos y/o solvatos de los mismos, para la preparacion de un medicamento destinado al tratamiento del asma persistente moderada
ARP070100019A 2006-01-04 2007-01-03 Uso de sales de tiotropio en el tratamiento del asma persistente moderada Pending AR059126A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP06100055 2006-01-04

Publications (1)

Publication Number Publication Date
AR059126A1 true AR059126A1 (es) 2008-03-12

Family

ID=35695896

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP070100019A Pending AR059126A1 (es) 2006-01-04 2007-01-03 Uso de sales de tiotropio en el tratamiento del asma persistente moderada

Country Status (30)

Country Link
US (2) US20070155773A1 (es)
EP (1) EP1971332B1 (es)
JP (1) JP2009525950A (es)
KR (1) KR20080083060A (es)
CN (1) CN101355937A (es)
AR (1) AR059126A1 (es)
AT (1) ATE500825T1 (es)
AU (1) AU2006334367B2 (es)
BR (1) BRPI0620886A2 (es)
CA (1) CA2634984C (es)
CY (1) CY1111534T1 (es)
DE (1) DE602006020620D1 (es)
DK (1) DK1971332T3 (es)
EA (1) EA015353B1 (es)
EC (1) ECSP088588A (es)
ES (1) ES2362306T3 (es)
HR (1) HRP20110200T1 (es)
IL (1) IL192602A (es)
ME (1) ME01205B (es)
MY (1) MY146362A (es)
NO (1) NO20082439L (es)
NZ (1) NZ570162A (es)
PL (1) PL1971332T3 (es)
PT (1) PT1971332E (es)
RS (1) RS51703B (es)
SI (1) SI1971332T1 (es)
TW (1) TW200731976A (es)
UA (1) UA95271C2 (es)
WO (1) WO2007077162A1 (es)
ZA (1) ZA200804436B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20080039974A (ko) 2005-08-06 2008-05-07 베링거 인겔하임 인터내셔날 게엠베하 중증 지속성 천식의 치료에서 티오트로퓸 염의 용도
WO2015065222A1 (ru) * 2013-10-28 2015-05-07 Шолекс Девелопмент Гмбх Фармацевтический ингаляционный препарат для лечения бронхиальной астмы и хронической обструктивной болезни легких, содержащий в качестве активного вещества микронизированный тиотропия бромид, и способ его получения
GB201321717D0 (en) * 2013-12-09 2014-01-22 Pharmachemie Bv Inhalable Medicaments
CN110876720A (zh) * 2018-09-06 2020-03-13 天津金耀集团有限公司 依地酸盐恰当改变噻托溴铵喷雾剂表面张力的应用
CN110876721A (zh) * 2018-09-06 2020-03-13 天津金耀集团有限公司 一种含有表面活性剂的噻托溴铵喷雾剂

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2425539A (en) * 1942-10-31 1947-08-12 Aro Equipment Corp Coupling
US5610163A (en) * 1989-09-16 1997-03-11 Boehringer Ingelheim Gmbh Esters of thienyl carboxylic acids and amino alcohols and their quaternization products
DE3931041C2 (de) * 1989-09-16 2000-04-06 Boehringer Ingelheim Kg Ester von Thienylcarbonsäuren mit Aminoalkoholen, ihre Quaternierungsprodukte, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
US6156503A (en) * 1997-03-03 2000-12-05 The Regents Of The University Of California Diagnosing asthma patients predisposed to adverse β-agonist reactions
GB9902689D0 (en) * 1999-02-08 1999-03-31 Novartis Ag Organic compounds
GB0009583D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Respiratory formulations
US6908928B2 (en) * 2000-10-12 2005-06-21 Bi Pharma Kg. Crystalline tiotropium bromide monohydrate, processes for the preparation thereof, and pharmaceutical compositions
MEP40008A (en) * 2000-10-12 2011-02-10 Boehringer Ingelheim Pharma Crystalline monohydrate, method for producing the same and the use thereof in the production of a medicament
US6608055B2 (en) * 2001-06-22 2003-08-19 Boehringer Ingelheim Pharma Kg Crystalline anticholinergic, processes for preparing it and its use for preparing a pharmaceutical composition
US6919325B2 (en) * 2001-09-14 2005-07-19 Boehringer Ingelheim Pharma Kg Pharmaceutical compositions containing tiotropium salts and low-solubility salmeterol salts
US7951557B2 (en) * 2003-04-27 2011-05-31 Protalix Ltd. Human lysosomal proteins from plant cell culture
ATE453641T1 (de) * 2003-11-03 2010-01-15 Boehringer Ingelheim Int Neues kristallines anhydrat mit anticholinerger wirksamkeit
SG137859A1 (en) * 2003-11-03 2007-12-28 Boehringer Ingelheim Int Method for producing tiotropium salts, tiotropium salts and pharmaceutical formulations, containing the same
US7968717B2 (en) * 2003-11-03 2011-06-28 Boehringer Ingelhein International Gmbh Crystalline anhydrate with anticholinergic efficacy
SE0303571D0 (sv) * 2003-12-03 2003-12-22 Microdrug Ag Medical product for moisture-sensitive medicaments
SE0303570L (sv) * 2003-12-03 2005-06-04 Microdrug Ag Fukt-känslig medicinsk produkt
EP1896607A4 (en) * 2005-05-10 2009-12-16 Synergenz Bioscience Ltd METHOD AND COMPOSITIONS FOR THE ASSESSMENT OF LUNG FUNCTION AND RESPIRATORY DISEASE
US7933722B2 (en) * 2005-05-20 2011-04-26 Synergenz Bioscience Limited Methods of analysis of polymorphisms and uses thereof
KR20080039974A (ko) * 2005-08-06 2008-05-07 베링거 인겔하임 인터내셔날 게엠베하 중증 지속성 천식의 치료에서 티오트로퓸 염의 용도
US20070167480A1 (en) * 2005-12-19 2007-07-19 Sicor Inc. Pure and stable tiotropium bromide

Also Published As

Publication number Publication date
HRP20110200T1 (hr) 2011-04-30
DK1971332T3 (da) 2011-04-18
EP1971332A1 (en) 2008-09-24
DE602006020620D1 (de) 2011-04-21
ME01205B (me) 2013-03-20
AU2006334367B2 (en) 2012-11-08
IL192602A0 (en) 2009-09-22
NO20082439L (no) 2008-08-04
AU2006334367A1 (en) 2007-07-12
NZ570162A (en) 2011-09-30
ZA200804436B (en) 2008-12-31
US20070155773A1 (en) 2007-07-05
JP2009525950A (ja) 2009-07-16
EP1971332B1 (en) 2011-03-09
TW200731976A (en) 2007-09-01
BRPI0620886A2 (pt) 2011-11-29
WO2007077162A1 (en) 2007-07-12
CA2634984A1 (en) 2007-07-12
CA2634984C (en) 2014-05-06
RS51703B (en) 2011-10-31
IL192602A (en) 2013-06-27
CN101355937A (zh) 2009-01-28
UA95271C2 (ru) 2011-07-25
KR20080083060A (ko) 2008-09-12
ECSP088588A (es) 2008-07-30
MY146362A (en) 2012-08-15
ATE500825T1 (de) 2011-03-15
ES2362306T3 (es) 2011-07-01
EA015353B1 (ru) 2011-06-30
SI1971332T1 (sl) 2011-05-31
CY1111534T1 (el) 2015-08-05
PT1971332E (pt) 2011-03-18
US20150224090A1 (en) 2015-08-13
EA200801629A1 (ru) 2008-12-30
PL1971332T3 (pl) 2011-08-31

Similar Documents

Publication Publication Date Title
ES2552237T3 (es) Composición para inhalación que contiene aclidinio para el tratamiento del asma
ECSP066460A (es) Formulación de aerosol destinada a la inhalación, que contiene un agente anticolinérgico
BRPI0515103A (pt) composição farmacêutica, inalador, processos para preparar o mesmo, e uma composição farmacêutica, e, uso de uma composição farmacêutica
AR059126A1 (es) Uso de sales de tiotropio en el tratamiento del asma persistente moderada
AR062424A1 (es) Formulacion en aerosol para la inhalacion de beta - agonistas
MY150519A (en) Imidazoquinolines with immuno-modulating properties
AR090349A1 (es) Terapia de combinacion para trastornos proliferativos, kit y uso
BR112012003283A2 (pt) sal farmaceuticamente aceitável de um agente fotossensibilizante anfifílico, composição farmacêutica, produto, kit, uso de um sal farmaceuticamente aceitável de um agente fotossensibilizante anfifílico, e, método de introdução de uma molécula de medicamento no citosol de uma célula em um paciente.
EA200901155A1 (ru) Модуляторы фармакокинетических свойств терапевтических препаратов (варианты) и их использование в терапии
WO2011098611A3 (en) Targeted alpha- particle emitting complexes comprising thorium radionuclide hydroxypyridinone containing ligand
AR058082A1 (es) Formulacion en aerosol para la inhalacion de beta- agonistas
MX2009004203A (es) Combinaciones de paracetamol/ibuprofeno y metodo para su uso.
CO6170341A2 (es) Formulacion de aerosol que contiene derivados de benzoxazin-3onas
TW200643013A (en) Pyrazoles
TW200639156A (en) New compounds
AR055597A1 (es) Uso de sales de tiotripio en el tratamiento del asma persistente severa
UY30736A1 (es) Compuestos quimicos 537
MX2010001574A (es) Ligandos del receptor cannabinoide.
UY28979A1 (es) Derivados de hidrocloruros de 3-carboxamida, composiciones farmacéuticas que los contienen, procedimiento de preparación y su uso, útiles como inhibidores selectivos de gsk3
EA201290833A1 (ru) Применение амисульприда в качестве противорвотного средства
PH12018502422A1 (en) Nanoliposomal irinotecan for use in treating small cell lung cancer
CO6220856A2 (es) Formas cristalinas de un compuesto de 8-azabiciclo[3,2,1]octano
AR049096A1 (es) Formulacion en aerosol sin gas propelente para la inhalacion de beta-agonistas
JP2015522025A5 (es)
TW200719899A (en) Tricyclic azole derivatives, their manufacture and use as pharmaceutical agents

Legal Events

Date Code Title Description
FB Suspension of granting procedure